Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia 2Uterine Cervical Neoplasms 1Stomatitis 1Neutropenia 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Blast Crisis 1

Interventions

Idarubicin 2Cytarabine 2fludarabine phosphate 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Isotretinoin 1Interferon-alpha 1Idoxuridine 1Drug Therapy 1Bromodeoxyuridine 1Biological Therapy 1BI 6727 1Arsenic Trioxide 1Antilymphocyte Serum 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myelomonocytic, Acute × Amifostine × Clear all
NCT00003405 2021-10-14

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Rush University Medical Center

Phase 2 Withdrawn
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡